Title 21

PART 369

Part 369 - Interpretative Statements Re Warnings On Drugs And Devices For Over-the-counter Sale

PART 369 - INTERPRETATIVE STATEMENTS RE WARNINGS ON DRUGS AND DEVICES FOR OVER-THE-COUNTER SALE Authority:21 U.S.C. 321, 331, 351, 352, 353, 355, 371. Source:39 FR 11745, Mar. 29, 1974, unless otherwise noted. Editorial Note:Nomenclature changes to part 369 appear at 69 FR 13717, Mar. 24, 2004.

21:5.0.1.1.32.1SUBPART A
Subpart A - Definitions and Interpretations
21:5.0.1.1.32.1.1.1SECTION 369.1
   369.1 Purpose of issuance.
21:5.0.1.1.32.1.1.2SECTION 369.2
   369.2 Definitions.
21:5.0.1.1.32.1.1.3SECTION 369.3
   369.3 Warnings required on drugs exempted from prescription-dispensing requirements of section 503(b)(1)(C).
21:5.0.1.1.32.1.1.4SECTION 369.4
   369.4 Warnings suggested for drugs by formal or informal statements of policy.
21:5.0.1.1.32.1.1.5SECTION 369.6
   369.6 [Reserved]
21:5.0.1.1.32.1.1.6SECTION 369.7
   369.7 Warnings required by official compendia.
21:5.0.1.1.32.1.1.7SECTION 369.8
   369.8 Warning statements in relation to conditions for use.
21:5.0.1.1.32.1.1.8SECTION 369.9
   369.9 General warnings re accidental ingestion by children.
21:5.0.1.1.32.1.1.9SECTION 369.10
   369.10 Conspicuousness of warning statements.
21:5.0.1.1.32.2SUBPART B
Subpart B - Warning and Caution Statements for Drugs
21:5.0.1.1.32.2.1.1SECTION 369.20
   369.20 Drugs; recommended warning and caution statements.
21:5.0.1.1.32.2.1.2SECTION 369.21
   369.21 Drugs; warning and caution statements required by regulations.